PLATINUM INVESTMENT MANAGEMENT LTD
13F Reported Value
ⓘ$406.7M
Holdings
85
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
PLATINUM INVESTMENT MANAGEMENT LTD disclosed 85 positions worth $406.7M in its Form 13F-HR for Q2 2026, led by $ZTO (ZTO Express (Cayman) Inc.) at 11.0% of the equity portfolio, followed by $MU and $LRCX. During the quarter the fund opened 10 new positions and exited 13 — including a new stake in $DDOG and a full exit from $TERN. The portfolio is most concentrated in Healthcare (28.9% of disclosed assets). All figures are sourced directly from PLATINUM INVESTMENT MANAGEMENT LTD’s Form 13F-HR filing with the SEC under CIK 1256071.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$44.6M1,994,127 sh - 86.2#4
Quality
$20.5M17,782 sh - 79.4#38
Quality
$20.1M46,439 sh - —
Quality
$14.0M351,921 sh - —
Quality
$12.5M6,486,507 sh - —
Quality
$9.9M993,612 sh - 84.5
Quality
$9.9M26,186 sh - —
Quality
$9.0M210,000 sh - —
Quality
$9.0M48,088 sh - 78.2
Quality
$8.7M24,592 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $44.6M | 1,994,127 | |
| 86.2#4 | $20.5M | 17,782 | |
| 79.4#38 | $20.1M | 46,439 | |
| — | $14.0M | 351,921 | |
| — | $12.5M | 6,486,507 | |
| — | $9.9M | 993,612 | |
| 84.5 | $9.9M | 26,186 | |
| — | $9.0M | 210,000 | |
| — | $9.0M | 48,088 | |
| 78.2 | $8.7M | 24,592 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of PLATINUM INVESTMENT MANAGEMENT LTD's 85 positions.
Showing top 10 of 85 holdings.
Sector Allocation
Healthcare
$117.4M
Industrials
$92.9M
Technology
$85.6M
Consumer Discretionary
$57.6M
Financials
$27.4M
Communication Services
$9.7M
Consumer Staples
$7.8M
Materials
$4.9M
Full Holdings — PLATINUM INVESTMENT MANAGEMENT LTD (Q2 2026)
All 85 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | ZTO Express (Cayman) Inc. | $44.6M | 11.0% | +0% | — | |
| 2 | MICRON TECHNOLOGY INC | $20.5M | 5.0% | -25% | 86.2 | |
| 3 | LAM RESEARCH CORP | $20.1M | 5.0% | +0% | 79.4 | |
| 4 | Trip.com Group Ltd | $14.0M | 3.5% | -7% | — | |
| 5 | Dingdong (Cayman) Ltd | $12.5M | 3.1% | +0% | — | |
| 6 | NOAH HOLDINGS LTD | $9.9M | 2.4% | +0% | — | |
| 7 | Broadcom Inc. | $9.9M | 2.4% | +0% | 84.5 | |
| 8 | Birkenstock Holding plc | $9.0M | 2.2% | -24% | — | |
| 9 | ASTRAZENECA PLC | $9.0M | 2.2% | +0% | — | |
| 10 | Alphabet Inc. | $8.7M | 2.1% | +0% | 78.2 | |
| 11 | Merck & Co., Inc. | $8.1M | 2.0% | +0% | 59.9 | |
| 12 | Apogee Therapeutics, Inc. | $7.7M | 1.9% | +0% | — | |
| 13 | AbbVie Inc. | $7.6M | 1.9% | +0% | 72.6 | |
| 14 | JOHNSON & JOHNSON | $7.1M | 1.7% | +0% | 69 | |
| 15 | YUM BRANDS INC | $6.4M | 1.6% | +0% | 73.7 | |
| 16 | PDD Holdings Inc. | $6.0M | 1.5% | +0% | — | |
| 17 | Cogent Biosciences, Inc. | $6.0M | 1.5% | +38% | — | |
| 18 | UBS Group AG | $5.8M | 1.4% | +0% | — | |
| 19 | NVIDIA CORP | $5.6M | 1.4% | +0% | 85.9 | |
| 20 | Immunovant, Inc. | $5.6M | 1.4% | -20% | — | |
| 21 | ARROWHEAD PHARMACEUTICALS, INC. | $5.3M | 1.3% | +0% | 38.7 | |
| 22 | IDEAYA Biosciences, Inc. | $5.2M | 1.3% | +51% | 36.1 | |
| 23 | IQVIA HOLDINGS INC. | $5.2M | 1.3% | +0% | 61.4 | |
| 24 | H World Group Ltd | $4.9M | 1.2% | +0% | — | |
| 25 | Vera Therapeutics, Inc. | $4.9M | 1.2% | +0% | — | |
| 26 | Structure Therapeutics Inc. | $4.8M | 1.2% | +35% | — | |
| 27 | VISA INC. | $4.8M | 1.2% | -7% | 82.9 | |
| 28 | CATERPILLAR INC | $4.8M | 1.2% | -47% | 66.5 | |
| 29 | ROGERS COMMUNICATIONS INC | $4.8M | 1.2% | +0% | — | |
| 30 | Amer Sports, Inc. | $4.7M | 1.2% | -7% | 64 | |
| 31 | KROGER CO | $4.5M | 1.1% | +34% | 52.6 | |
| 32 | KLA CORP | $4.4M | 1.1% | +900% | 78.6 | |
| 33 | CAMECO CORP | $4.3M | 1.1% | +0% | — | |
| 34 | ADVANCED MICRO DEVICES INC | $4.2M | 1.0% | +0% | 79.8 | |
| 35 | Arcus Biosciences, Inc. | $4.1M | 1.0% | +0% | 8.5 | |
| 36 | ADOBE INC. | $3.8M | 0.9% | +0% | 77.6 | |
| 37 | Floor & Decor Holdings, Inc. | $3.7M | 0.9% | -7% | 54.5 | |
| 38 | Meta Platforms, Inc. | $3.7M | 0.9% | +30% | 79.6 | |
| 39 | PALISADE BIO, INC. | $3.6M | 0.9% | +41% | — | |
| 40 | Dutch Bros Inc. | $3.6M | 0.9% | -5% | 63.6 | |
| 41 | FAIR ISAAC CORP | $3.6M | 0.9% | -12% | 77.7 | |
| 42 | GE Vernova Inc. | $3.6M | 0.9% | +0% | 81.1 | |
| 43 | HOME DEPOT, INC. | $3.5M | 0.9% | -13% | 60.3 | |
| 44 | Valaris Ltd | $3.3M | 0.8% | +0% | — | |
| 45 | e.l.f. Beauty, Inc. | $3.3M | 0.8% | -38% | 58.2 | |
| 46 | CAVA GROUP, INC. | $3.3M | 0.8% | -7% | 57.1 | |
| 47 | Definium Therapeutics, Inc. | $3.3M | 0.8% | +0% | — | |
| 48 | Roivant Sciences Ltd. | $3.3M | 0.8% | +0% | — | |
| 49 | TransUnion | $3.2M | 0.8% | +0% | 65.6 | |
| 50 | Revolution Medicines, Inc. | $3.2M | 0.8% | -18% | — | |
| 51 | Datadog, Inc. | $3.1M | 0.8% | NEW | 71.4 | |
| 52 | BridgeBio Pharma, Inc. | $3.0M | 0.7% | -19% | 36.9 | |
| 53 | Wingstop Inc. | $2.9M | 0.7% | +42% | 62.4 | |
| 54 | Intercontinental Exchange, Inc. | $2.9M | 0.7% | +0% | 73.7 | |
| 55 | EchoStar CORP | $2.8M | 0.7% | +120% | 32.8 | |
| 56 | Vertiv Holdings Co | $2.8M | 0.7% | -18% | 81 | |
| 57 | Absci Corp | $2.8M | 0.7% | +0% | 7 | |
| 58 | Zymeworks Inc. | $2.7M | 0.7% | +0% | 8.7 | |
| 59 | Motorola Solutions, Inc. | $2.6M | 0.6% | +0% | 71.8 | |
| 60 | MBX Biosciences, Inc. | $2.4M | 0.6% | +0% | — | |
| 61 | Booking Holdings Inc. | $2.2M | 0.6% | +2400% | 58.5 | |
| 62 | ANALOG DEVICES INC | $2.2M | 0.5% | NEW | 79.2 | |
| 63 | ProQR Therapeutics N.V. | $2.2M | 0.5% | -6% | — | |
| 64 | NETFLIX INC | $2.1M | 0.5% | -40% | 78.8 | |
| 65 | ServiceNow, Inc. | $2.0M | 0.5% | NEW | 72.9 | |
| 66 | DoorDash, Inc. | $1.8M | 0.5% | NEW | 71 | |
| 67 | C4 Therapeutics, Inc. | $1.8M | 0.4% | +0% | 18.2 | |
| 68 | Palo Alto Networks Inc | $1.6M | 0.4% | NEW | 65.5 | |
| 69 | Wave Life Sciences, Inc. | $1.6M | 0.4% | +0% | 7.5 | |
| 70 | IDEXX LABORATORIES INC /DE | $1.5M | 0.4% | -3% | 73.8 | |
| 71 | BRIGHT MINDS BIOSCIENCES INC. | $1.3M | 0.3% | +0% | — | |
| 72 | Stoke Therapeutics, Inc. | $1.3M | 0.3% | +0% | 24.9 | |
| 73 | M-tron Industries, Inc. | $1.3M | 0.3% | NEW | 61.1 | |
| 74 | COSTAR GROUP, INC. | $1.1M | 0.3% | -48% | 57.8 | |
| 75 | A10 Networks, Inc. | $1.1M | 0.3% | NEW | 58.4 | |
| 76 | Block, Inc. | $950,000 | 0.2% | NEW | 51.8 | |
| 77 | Aura Biosciences, Inc. | $794,242 | 0.2% | +0% | — | |
| 78 | JD.com, Inc. | $730,002 | 0.2% | +0% | — | |
| 79 | Zoetis Inc. | $718,600 | 0.2% | -76% | 68.6 | |
| 80 | S&P Global Inc. | $686,233 | 0.2% | NEW | 76.1 | |
| 81 | ADC Therapeutics SA | $622,322 | 0.1% | -41% | 21.8 | |
| 82 | CODEXIS, INC. | $597,689 | 0.1% | +0% | 28.9 | |
| 83 | Inhibrx Biosciences, Inc. | $582,334 | 0.1% | NEW | 30 | |
| 84 | Alibaba Group Holding Ltd | $411,082 | 0.1% | +0% | — | |
| 85 | Skye Bioscience, Inc. | $161,605 | 0.0% | +0% | — |
New Positions (10)
Exited Positions (13)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for PLATINUM INVESTMENT MANAGEMENT LTD including:
Track PLATINUM INVESTMENT MANAGEMENT LTD's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for PLATINUM INVESTMENT MANAGEMENT LTD and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: PLATINUM INVESTMENT MANAGEMENT LTD
13F Pro is an AI hedge fund tracker and stock research platform. For PLATINUM INVESTMENT MANAGEMENT LTD (SEC CIK: 1256071), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in PLATINUM INVESTMENT MANAGEMENT LTD's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.